Reimportation Survey Demonstrates Rx Industry’s Public Relations Challenge
Pharmaceutical companies' opposition to importing drugs from Canada into the U.S. is "unreasonable," according to a survey of Americans released Oct. 9
You may also be interested in...
Direct-to-consumer advertising for follow-on drugs such as AstraZeneca's Nexium are part of the reason for "huge" Medicaid spending on prescription drugs, Centers for Medicare & Medicaid Services Administrator Thomas Scully told a House Energy & Commerce/Health Subcommittee hearing Oct. 8
Pending federal legislation to allow importation of prescription drugs from Canada would create unworkable conflicts with state pharmacy laws, FDA Commissioner Mark McClellan told the National Association of Boards of Pharmacy legislative conference Sept. 14 in Washington, D.C
Alternatives to passing a full Medicare prescription drug benefit will be given their first public airing since the Medicare conference committee was formed when the House Government Reform/Human Rights & Wellness Subcommittee convenes for a hearing Sept. 24